Authors:
Camino, X
Iribarren, JA
Arrizabalaga, J
Rodriguez, F
von Wichmann, MA
Citation: X. Camino et al., Causes of mortality among patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy, ENFERM INF, 19(2), 2001, pp. 85-86
Authors:
von Wichmann, MA
Camino, X
Txoperena, G
Arrizabalaga, J
Rodriguez-Arrondo, F
Iribarren, JA
Citation: Ma. Von Wichmann et al., Granulocyte colony-stimulating factor administration in human immunodeficiency virus-infected patients with prolonged neutropenia, ENFERM INF, 19(1), 2001, pp. 19-23
Authors:
Ruiz-Sanz, JI
Aldamiz-Echevarria, L
Arrizabalaga, J
Aquino, L
Jimeno, P
Perez-Nanclares, G
Sanjurjo, P
Citation: Ji. Ruiz-sanz et al., Polyunsaturated fatty acid deficiency during dietary treatment of very long-chain acyl-CoA dehydrogenase deficiency. Rescue with soybean oil, J INH MET D, 24(4), 2001, pp. 493-503
Authors:
Garcia, F
Alonso, MM
Romeu, J
Knobel, H
Arrizabalaga, J
Ferrer, E
Dalmau, D
Ruiz, I
Vidal, F
Frances, A
Segura, F
Gomez-Sirvent, JL
Cruceta, A
Clotet, B
Pumarola, T
Gallart, T
O'Brien, WA
Miro, JM
Gatell, JM
Citation: F. Garcia et al., Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish Earth-2 Study, J ACQ IMM D, 25(1), 2000, pp. 26-35
Authors:
Podzamczer, D
Miro, JM
Ferrer, E
Gatell, JM
Ramon, JM
Ribera, E
Sirera, G
Cruceta, A
Knobel, H
Domingo, P
Polo, R
Leyes, M
Cosin, J
Farinas, MC
Arrizabalaga, J
Martinez-Lacasa, J
Gudiol, F
Citation: D. Podzamczer et al., Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients, EUR J CL M, 19(2), 2000, pp. 89-95
Authors:
Garcia, F
Knobel, H
Sambeat, MA
Arrizabalaga, J
Aranda, M
Romeu, J
Dalmau, D
Segura, F
Gomez-Sirvent, JL
Ferrer, E
Cruceta, A
Gallart, T
Pumarola, T
Miro, JM
Gatell, JM
Citation: F. Garcia et al., Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study, AIDS, 14(16), 2000, pp. 2485-2494
Authors:
Negredo, E
Paredes, R
Bonjoch, A
Tuldra, A
Fumaz, CR
Gel, S
Garces, B
Johnston, S
Arno, A
Balague, M
Jou, A
Tural, C
Sirera, G
Romeu, J
Cruz, L
Francia, E
Domingo, P
Arrizabalaga, J
Ruiz, I
Arribas, JR
Ruiz, L
Clotet, B
Citation: E. Negredo et al., Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up, ANTIVIR TH, 4, 1999, pp. 23-28
Authors:
Garcia, F
Romeu, J
Grau, I
Sambeat, MA
Dalmau, D
Knobel, H
Gomez-Sirvent, JL
Arrizabalaga, J
Cruceta, A
Clotet, B
Podzamczer, D
Pumarola, T
Gallart, T
O'Brien, WA
Miro, JM
Gatell, JM
Citation: F. Garcia et al., A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study, AIDS, 13(17), 1999, pp. 2377-2388
Authors:
Casado, JL
Arrizabalaga, J
Montes, M
Marti-Belda, P
Tural, C
Pinilla, J
Gutierrez, C
Portu, J
Schuurman, R
Aguirrebengoa, K
Citation: Jl. Casado et al., Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy, AIDS, 13(12), 1999, pp. 1497-1502
Citation: J. Arrizabalaga, Medical causes of death in preindustrial Europe: Some historiographical considerations, J HIST MED, 54(2), 1999, pp. 241-260
Authors:
Arrondo, FR
von Wichmann, MA
Arrizabalaga, J
Iribarren, JA
Garmendia, G
Idigoras, P
Citation: Fr. Arrondo et al., Lung cavitation in patients with human immunodeficiency virus infection: analysis in 78 cases, MED CLIN, 111(19), 1998, pp. 725-730